[1]李 星,田春燕,王丽洁,等.李竹英教授治疗哮喘经验[J].陕西中医杂志,2022,(7):936-938.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.030]
　LI Xing,TIAN Chunyan,WANG Lijie,et al.Professor LI Zhuying's experience in treating asthma[J].,2022,(7):936-938.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.030]
点击复制

李竹英教授治疗哮喘经验
分享到：

《陕西中医》杂志[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2022年7期
页码:
936-938
栏目:
名中医经验
出版日期:
2022-07-05

文章信息/Info

Title:
Professor LI Zhuying's experience in treating asthma
作者:
李 星1; 田春燕1; 王丽洁1; 王 岩2; 金 岩1
(1.黑龙江中医药大学附属第一医院,黑龙江 哈尔滨 150040; 2.通河县人民医院,黑龙江 通河 150900)
Author(s):
LI Xing; TIAN Chunyan; WANG Lijie; WANG Yan; JIN Yan
(First Affiliated Hospital of Heilongjiang University of Chinese Medicine,Harbin 150040,China)
关键词:
哮喘;  李竹英;  名医经验;  阳虚痰瘀;  温阳益气;  散瘀化痰
Keywords:
Asthma;  LI Zhuying;  Experience of wellknown doctors;  Yang deficiency and phlegm stasis;  Warm Yang and benefit Qi;  Dispel phlegm and resolve phlegm
分类号:
R 562.2
DOI:
DOI:10.3969/j.issn.1000-7369.2022.07.030
文献标志码:
A
摘要:
李竹英教授是黑龙江省名中医、黑龙江省名中医学术经验继承工作指导老师。文章通过对李竹英教授的临床经验进行总结,阐述了李竹英教授对哮喘病机“阳虚痰瘀”的认识。李竹英教授认为痰、瘀、虚是哮喘发病主要病机。李竹英教授治疗哮喘经验如下:第一,温阳益气为本,治疗哮喘应注重温补肺阳; 第二,散瘀化痰并重,哮喘发病痰瘀与血瘀同时存在,治疗时酌加活血之品; 第三,缓解期要固本防复。
Abstract:
Professor LI Zhuying is a famous traditional Chinese medicine doctor and the teacher of academic experience inheritance of famous traditional Chinese medicine in Heilongjiang province.The article describes professor LI Zhuying's understanding of the pathogenesis of asthma “Yang deficiency,phlegm and stasis”.Professor LI Zhuying believes that phlegm,blood stasis and deficiency are the main pathogenesis of asthma.Professor LI Zhuying's experience in treating asthma is as follows:First,warming Yang and invigorating Qi is the basis of asthma treatment,the treatment of asthma should focus on warming and tonifying lung Yang.Second,we should pay equal attention to dispersing stasis and eliminating phlegm.Phlegm and blood stasis coexist in asthma,and blood activating products should be added in treatment.Thirdly,during the remission period,it is necessary to strengthen the root and prevent recurrence.

参考文献/References:

[1] 刘 玉,唐雪春.初诊哮喘患者中医临床证型和体制类型调查报告分析[J].辽宁中医杂志,2010,37(10):1920-1921.
[2] 方春仙,杨珺超.中医体质类型与非急性发作期支气管哮喘的相关性研究[J].浙江中医药大学学报,2012,36(5):519-521.
[3] 李风森,李明霞,王惠妩.乌鲁木齐地区1150例支气管哮喘患者中医证型临床研究[J].中华中医药杂志,2011,26(1):192-194.
[4] 孙慧媛,孙瑞华,张秀艳,等.基于临床流行病学的支气管哮喘慢性持续期证候特征研究[J].中华中医药杂志,2016,31(11):4494-4498.
[5] 刘建秋,高风丽,李竹英.温阳益气化痰平喘方治疗支气管哮喘慢性持续期临床研究[J].中国中医急症,2014,23(12):2172-2173,2219.
[6] Wang X,Tian Z,Gao F,et al.Traditional Chinese medicine as an adjunctive therapy to oral montelukast for treating patients with chronic asthma[J].Medicine(Baltimore),2017,96(51):e9291.
[7] 石义兵,郭小龙.活血定喘汤对支气管哮喘患儿气道炎症及炎性因子水平的影响[J].陕西中医,2020,41(11):1602-1606.
[8] 王 玉.益气活血贴联合雾化吸入布地奈德治疗小儿急性哮喘的效果分析[J].陕西中医,2016,37(10):1301-1303.
[9] 周 静,庞 剑.大柴胡汤合桂枝茯苓丸对瘀血型慢性支气管哮喘临床疗效观察[J].辽宁中医药大学学报,2014,16(6):146-147.
[10] 徐 路,张 琦.桂枝茯苓丸临床应用概况[J].河南中医,2015,35(9):2031-2034.
[11] Hur GY,Broide DH.Genes and pathways regulating decline in lung function and airway remodeling in asthma[J].Allergy Asthma Immunol Res,2019,11(5):604-621.
[12] Tian C,Gao F,Li X,et al.Icariside Ⅱ attenuates eosinophils-induced airway inflammation and remodeling via inactivation of NF-κB and STAT3 in an asthma mouse model [J].Exp Mol Pathol,2020,113:104373.
[13] 陈江华,顾向明.哮喘患者血瘀状态凝血功能的初步实验数据研究[J].云南中医中药杂志,2007,28(12):8-9.
[14] 李 星,王丽洁,李寒梅,等.外周血嗜酸性粒细胞比率及血小板参数与支气管哮喘相关性研究[J].现代生物医学进展,2021,21(16):3142-3146.
[15] 朱小川.血小板/淋巴细胞比值预测慢性阻塞性肺疾病急性加重期伴有早期肾功能损害临床价值[J].陕西医学杂志,2019,48(10):1352-1354,1392.
[16] 时 光,赵俊伟,明 亮.哮喘患者外周血血小板-淋巴细胞比值和中性粒细胞-淋巴细胞比值的临床意义[J].南方医科大学学报,2017,37(1):84-88.
[17] Lefrancais E,Ortiz-munoz G,Caudrillier A,et al.The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors [J].Nature,2017,544(7648):105-109.
[18] 贺小丽.丹地桃仁汤治疗哮喘31例[J].黑龙江中医药,2006,49(5):7-8.
[19] 王志旺,李荣科,刘雪枫.当归对阴虚哮喘小鼠模型的影响[J].中国实验方剂学杂志,2016,22(21):116-120.
[20] 杨毅勇,陈晓宏.养阴活血通络汤治疗阴虚血瘀型稳定期支气管哮喘的临床观察[J].上海中医药杂志,2016,50(6):46-48.
[21] 李竹英,陈 璐,李 星.刘建秋敷穴化痰膏穴位贴敷治疗缓解期哮喘经验[J].上海中医药杂志,2018,52(9):29-31,37.

相似文献/References:

[1]李艳,曾晓翠.加味射干麻黄汤对小儿咳嗽变异性哮喘的疗效观察[J].陕西中医杂志,2016,(10):1311.
[2]伍 磊.紫苏子汤对哮喘小鼠TNFα、白细胞介素8、白介素1β表达的影响*[J].陕西中医杂志,2019,(2):152.
　WU Lei..Effects of Zisuzi decoction on expression of TNF α，interleukin 8 and interleukin 1 β in asthmatic mice[J].,2019,(7):152.
[3]王玉梅,袁向东,李四保.止咳平喘糖浆联合异丙托溴铵治疗哮喘疗效及对患儿肺功能和内环境的影响*[J].陕西中医杂志,2019,(4):428.
　WANG Yumei,YUAN Xiangdong,LI Sibao..Curative effect of cough relieving asthma syrup combined with ipratropium bromide on children with asthma and its influence on pulmonary function and internal environment[J].,2019,(7):428.
[4]汪 伟,赵跃萍,张亚明.补中益气方联合针灸治疗哮喘疗效及对患儿大气道功能相关指标的影响*[J].陕西中医杂志,2020,(11):1611.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.025]
　WANG Wei,ZHAO Yueping,ZHANG Yaming..Effect of Buzhong Yiqi recipe combined with acupuncture and moxibustion on therapeutic effect and changes of large airway function indexes in children with asthma[J].,2020,(7):1611.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.025]
[5]陈训春,李名兰,潘碧云,等.白芥子散对哮喘大鼠免疫稳态重建及RhoA基因表达的影响[J].陕西中医杂志,2021,(7):836.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.005]
　CHEN Xunchun,LI Minglan,PAN Biyun,et al.Immune steady-state reconstruction of sputum drug Baijiezi powder on asthmatic rats and its effect on RhoA gene expression[J].,2021,(7):836.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.005]
[6]刘 健,王佳丽,曹慧丹,等.补肺颗粒对哮喘小鼠气道重塑的影响及机制研究[J].陕西中医杂志,2022,(5):559.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.004]
　LIU Jian,WANG Jiali,CAO Huidan,et al.Mechanism of Bufei granule inhibiting airway remodeling in asthmatic mice[J].,2022,(7):559.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.004]
[7]陆振瑜,庄 承.益气补肾止喘汤联合布地奈德治疗小儿哮喘疗效研究[J].陕西中医杂志,2022,(6):728.[doi:DOI:10.3969/j.issn.1000-7369.2022.06.012]
　LU Zhenyu,ZHUANG Cheng.Effect research on Yiqi Bushen Zhichuan decoction combined with budesonide treatment of children with asthma[J].,2022,(7):728.[doi:DOI:10.3969/j.issn.1000-7369.2022.06.012]
[8]孙境孺,李竹英.NF-κB信号通路在肺部疾病中的作用研究进展及中医药干预现状[J].陕西中医杂志,2022,(7):972.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.039]
　SUN Jingru,LI Zhuying.Research progress of role of NF-κB signaling pathway in lung diseases and the current situation of traditional Chinese medicine intervention[J].,2022,(7):972.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.039]
[9]梁 嫄,于海洋,司秀影,等.中药调控Notch通路治疗哮喘作用机制研究进展[J].陕西中医杂志,2022,(7):975.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.040]
　LIANG Yuan,YU Haiyang,SI Xiuying,et al.Research progress on mechanism of traditional Chinese medicine regulating Notch pathway in treating asthma[J].,2022,(7):975.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.040]
[10]沈世平,薛 征.虫类中药治疗儿童支气管哮喘研究进展[J].陕西中医杂志,2022,(10):1484.[doi:DOI:10.3969/j.issn.1000-7369.2022.10.041]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助面上项目(82074365); 黑龙江省第二批省级名中医专家传承工作室建设项目(202143024); 中国民族医药学会科研项目(2020ZY105-510801); 黑龙江省中医药科研项目(ZHY2020-108)
更新日期/Last Update: 2022-07-07